1 Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
2 Center for Disease Analysis Foundation, Lafayette, Colorado, United States.
3 Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
4 Department of Medicine Huddinge, Karolinska Institutet, Sweden.
5 Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.
6 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.
7 Faculty of Medicine, Imperial College London, United Kingdom.
8 Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
9 Institute of clinical medicine, University of Oslo, Oslo, Norway.
10 Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
11 The Kirby Institute, UNSW Sydney, Sydney, Australia.
12 Department of Infectious Diseases, School of Medical Sciences, Örebro University, Örebro, Sweden.
13 Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
14 Institute for Global Health, University College London, London, United Kingdom.
15 School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
16 Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
17 CHIP, WHO Collaborating Centre on HIV and Viral Hepatitis, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Cascade-of-care (CoC) monitoring is an important component of the response to the global hepatitis C virus (HCV) epidemic. CoC metrics can be used to communicate in simple terms the extent to which national and subnational governments are advancing on key targets, and CoC findings can inform strategic decision-making regarding how to maximize the progression of HCV-infected individuals to diagnosis, treatment and cure. The value of reporting would be enhanced if reporting entities utilized a standardized approach for generating their CoCs. We have described the Consensus HCV CoC that we developed to address this need and have presented findings from Denmark, Norway and Sweden, where it was piloted. We encourage the uptake of the Consensus HCV CoC as a global instrument for facilitating clear and consistent reporting via the World Health Organization (WHO) viral hepatitis monitoring platform and ensuring the accurate monitoring of progress toward WHO's 2030 hepatitis C elimination targets.